| RS35291173 |
ZNF335
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF335-related disorder, ZNF335-related disorder |
| RS35291591 |
HBB
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN MCKEES ROCKS, Erythrocytosis |
| RS35294392 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS35296328 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS35297901 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS35300056 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS35301433 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS35302901 |
ROS1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS35306038 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Seckel syndrome 1 |
| RS35309576 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS35311343 |
TLR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 83, susceptibility to viral infections |
| RS35312232 |
TGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS35313315 |
MED17
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly, Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly |
| RS35313369 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
RTTN-related disorder, RTTN-related disorder |
| RS35315400 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, Inborn genetic diseases |
| RS35315829 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS35321913 |
HBG1
|
Health Risk |
Pathogenic |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS35324967 |
HBD
|
Health Risk |
Pathogenic |
delta Thalassemia, delta Thalassemia |
| RS35327474 |
MBL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mannose-binding lectin deficiency, Mannose-binding lectin deficiency |
| RS35327842 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Inborn genetic diseases |
| RS35328027 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS35328240 |
SFTPB
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS35328937 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS35329429 |
PRF1
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS35330765 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS35331711 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, CP-related disorder |
| RS35333334 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucolipidosis type II |
| RS35334949 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35336155 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, Usher syndrome type 1C |
| RS35337543 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS35339834 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, intellectual disability |
| RS35343277 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, Autosomal dominant cerebellar ataxia |
| RS35346077 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Hereditary cancer-predisposing syndrome |
| RS35346129 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Connective tissue disorder |
| RS35347543 |
LARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35348864 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, Dominant beta-thalassemia |
| RS35350789 |
LMBRD1
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |
| RS35350960 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gilbert syndrome, Crigler-Najjar syndrome |
| RS35351128 |
HBB
|
Health Risk |
Pathogenic; other |
HEMOGLOBIN VANDERBILT, Erythrocytosis |
| RS35351345 |
CLCNKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonpapillary renal cell carcinoma, Ovarian cancer |
| RS35353749 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS35353912 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS35355795 |
PEG3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35359501 |
WAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Wiskott-Aldrich syndrome, X-linked severe congenital neutropenia |
| RS353612 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS353618 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS35361862 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS353623 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS353630 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS353637 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS353647 |
CD44
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS35369023 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS35369423 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS35370270 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35371965 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS35373464 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS35378785 |
DSG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotrichosis 6, DSG4-related disorder |
| RS35378915 |
HBG1
|
Health Risk |
Pathogenic |
Sardinian HPFH, Greek HPFH |
| RS35379711 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS35382573 |
SCAPER
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, SCAPER-related disorder |
| RS35383271 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS35383398 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, Hemoglobinopathy |
| RS35389822 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS35393416 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, COG5-related disorder |
| RS35395625 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, beta Thalassemia |
| RS35396083 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS35398714 |
SLC24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1D, Inborn genetic diseases |
| RS35401252 |
TPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS35401386 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS35403035 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKHD1-related disorder, Autosomal recessive polycystic kidney disease |
| RS35405661 |
DPF2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 7, Coffin-Siris syndrome 7 |
| RS35413340 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS35414700 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS35417190 |
MBTPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MBTPS1-related disorder |
| RS35417728 |
FRY
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35424040 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN KNOSSOS, BETA-PLUS-THALASSEMIA |
| RS35426017 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS35428353 |
GPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Transient infantile hypertriglyceridemia and hepatosteatosis, GPD1-related disorder |
| RS35429253 |
B4GAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 |
| RS35429535 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS35433680 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Sarcoma |
| RS35434090 |
SLC25A15
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS35434411 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS35436690 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS35441257 |
ORC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Meier-Gorlin syndrome 3, Meier-Gorlin syndrome 3 |
| RS35441529 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, ARID1B-related disorder |
| RS35442268 |
FBN3
|
Health Risk |
Conflicting classifications of pathogenicity |
FBN3-related disorder, FBN3-related disorder |
| RS35442324 |
DHTKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
2-aminoadipic 2-oxoadipic aciduria, Inborn genetic diseases |
| RS35447806 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, MYO3A-related disorder |
| RS35448266 |
AMACR
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-methylacyl-CoA racemase deficiency, Alpha-methylacyl-CoA racemase deficiency |
| RS35449699 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS35450031 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS35456792 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS35456885 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS35459559 |
HNRNPR
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities, Inborn genetic diseases |
| RS35460901 |
KCND2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, Inborn genetic diseases |
| RS35461188 |
ARMC5
|
Health Risk |
Likely pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS35462442 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS35469582 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS35469724 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, Inborn genetic diseases |